Filing Details

Accession Number:
0000950157-18-000023
Form Type:
5
Zero Holdings:
No
Publication Time:
2018-01-02 13:39:01
Reporting Period:
2017-12-31
Accepted Time:
2018-01-02 13:39:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1505451 Linde North America, Inc. 200 Somerset Corporate Boulevard
Bridgewater NJ 08807
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-29 1,920,000 $0.00 5,271,796 No 4 P Direct
Common Stock Acquisiton 2017-09-29 1,721,992 $0.00 5,271,796 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2016-11-29 1,920,000 $0.00 1,920,000 $0.80
Common Stock Common Stock Warrants (right to buy) Acquisiton 2017-09-29 1,721,992 $0.00 1,721,992 $1.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,920,000 2021-11-29 No 5 P Direct
1,721,992 2022-09-29 No 5 P Direct
Footnotes
  1. The reported securities are included within Units purchased by the reporting person for $0.70 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
  2. The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
  3. The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.
  4. The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.